Cite
HARVARD Citation
Goldkorn, A. et al. (n.d.). Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial. International journal of cancer. 136 (8), pp. 1856-1862. [Online].